NEWS

1) Sho Masui et al. Biol. Pharm. Bull. 46, 1112–1119 (2023)
Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis

2) Taiji Hamada et al. BMC Cancer (2023) 23:424
MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer

3) Chisato Terada et al. Nature Communications | (2023) 14:7972
Dynamic and static control of the off-target interactions of antisense oligonucle

4) Shuuichi Mori et al. Experimental Neurology 361 (2023) 114300
Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis

5) Toshiaki Nonaka et al. BMC Neurology (2024) 24:92
Detection limitations of prion seeding activities in blood samples from patients with sporadic prion disease

6) Feifei Wei et al. Computational and Structural Biotechnology Journal 23 (2024) 859–869
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation

7) Hideo Tashiro et al. Analytical Biochemistry 703 (2025) 115865
Highly-sensitive peptide array using peptides immobilized on microbeads:Application to cow’s milk allergy analysis

8) Masayuki Morito et al. Anal. Chem. 2025, 97, 8880−8889
Comprehensive Identification of Lipid−Membrane Protein Interactions via Advanced Proteomics and Extended LipidImmobilized Bead Technology